ANERGIS S A has a total of 19 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are JACKSON SIMON MARK, CUBIST PHARMACEUTICALS LLC and MEHTA NOZER M.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | EPO (European Patent Office) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Reymond Christophe | 14 |
#2 | Spertini Francois | 12 |
#3 | Kettner Alexander | 7 |
#4 | Corthesy Blaise | 3 |
#5 | Amacker Mario | 2 |
#6 | Fleury Sylvain | 2 |
#7 | Charlon Vincent | 2 |
#8 | Beltrami Vanya | 2 |
#9 | Stegmann Antonius Johannes Henrikus | 1 |
#10 | Stegmann Antonius Johannes | 1 |
Publication | Filing date | Title |
---|---|---|
US2020188511A1 | Methods of improving efficacy of allergy vaccines | |
AU2012277491B2 | Contiguous overlapping peptides for treatment of ragweed pollen allergy | |
US7923209B2 | Allergen peptide fragments and use thereof |